These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Chrysotherapy in rheumatoid polyarthritis]. Suţeanu S; Moangă M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):107-12. PubMed ID: 6139855 [No Abstract] [Full Text] [Related]
3. [2 cases of kidney damage during the treatment with gold preparations]. Wanic-Kossowska M; Turczak-Bierła I; Grzegorzewska A Przegl Lek; 1990; 47(11):788-90. PubMed ID: 2129137 [No Abstract] [Full Text] [Related]
4. Low incidence of proteinuria in RA after gold thiosulfate treatment. Salvarini C; Macchioni P; Zizzi F; Rossi F; Baricchi R; Mantovani W; Ghirelli L; Capozzoli N; Frizziero L; Portioli I J Rheumatol; 1990 Feb; 17(2):271-2. PubMed ID: 2108247 [No Abstract] [Full Text] [Related]
5. [Chrysotherapy and side effects (author's transl)]. Eberl R Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096 [No Abstract] [Full Text] [Related]
6. [Lichen ruber pemphigoid in gold treatment of rheumatoid arthritis]. Wozel G; Rietzschel I; Heidenbluth I Dermatol Monatsschr; 1983 Feb; 169(2):125-9. PubMed ID: 6404668 [No Abstract] [Full Text] [Related]
7. [Treatment with gold salts and systemic erythematosus]. Strejcek J Cas Lek Cesk; 1983 Apr; 122(15):469-72. PubMed ID: 6407754 [No Abstract] [Full Text] [Related]
8. Chrysotherapy in rheumatoid arthritis. Myers AR Mod Treat; 1971 Nov; 8(4):761-8. PubMed ID: 4258496 [No Abstract] [Full Text] [Related]
9. Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. Ferraccioli G; Peri F; Nervetti A; Ambanelli U; Savi M J Rheumatol; 1986 Feb; 13(1):65-8. PubMed ID: 3084782 [TBL] [Abstract][Full Text] [Related]
10. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Bax DE; Amos RS Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182 [TBL] [Abstract][Full Text] [Related]